LGC opens $72M chemical plant; Recipharm partners with NeuroSense news2025-09-11T15:12:39+00:00September 11th, 2025|Endpoints News|
Biocon eyes generic semaglutide market for 2026news2025-09-10T19:00:54+00:00September 10th, 2025|Endpoints News|
API maker Hikal hit with FDA warning letter over alleged metal contaminationnews2025-09-10T15:22:44+00:00September 10th, 2025|Endpoints News|
FDA blocks US imports from Sun Pharma’s Halol site over repeated issuesnews2025-09-10T13:59:27+00:00September 10th, 2025|Endpoints News|
Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer news2025-09-09T16:38:49+00:00September 9th, 2025|Endpoints News|
Trump may exempt some pharma products from tariffs in future trade dealsnews2025-09-09T15:30:14+00:00September 9th, 2025|Endpoints News|
FDA is readying more surprise inspections for foreign drug sites, Makary saysnews2025-09-05T17:36:12+00:00September 5th, 2025|Endpoints News|
Japan-made generic drugs will be exempt from Trump’s reciprocal tariff news2025-09-05T13:34:38+00:00September 5th, 2025|Endpoints News|
AstraZeneca ends manufacturing license at Indian plant as it exits the site news2025-09-04T16:16:12+00:00September 4th, 2025|Endpoints News|
Exothera shutters; Lotte Biologics’ latest contract with an unnamed US clientnews2025-09-04T14:19:31+00:00September 4th, 2025|Endpoints News|
